T1	Participants 116 154	advanced head and neck cancer patients
T2	Participants 587 763	successive patients with unresectable grade I/II head and neck cancer who were not suitable for irradiation treatment (T any N3 or T4 N2C), metastatic or previously irradiated.
T3	Participants 888 911	A total of 170 patients
